Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 5 » default
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (571)
- Volume 16, 2023 (47)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Archive: Volume 5, 2012
CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients
Sirachainan E, Jaruhathai S, Trachu N, Panvichian R, Sirisinha T, Ativitavas T, Ratanatharathorn V, Chamnanphon M, Sukasem C
Pharmacogenomics and Personalized Medicine 2012, 5:149-153
Published Date: 17 October 2012
Drug targets and predictive biomarkers in the management of metastatic melanoma
Thumar J, Giesen E, Kluger HM
Pharmacogenomics and Personalized Medicine 2012, 5:139-148
Published Date: 28 September 2012
Boceprevir and personalized medicine in hepatitis C virus infection
Habersetzer F, Leboeuf C, Doffoël M, Baumert TF
Pharmacogenomics and Personalized Medicine 2012, 5:125-137
Published Date: 26 September 2012
Personalized medicine and treatment approaches in non-small-cell lung carcinoma
Vadakara J, Borghaei H
Pharmacogenomics and Personalized Medicine 2012, 5:113-123
Published Date: 25 September 2012
Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent
AL-Eitan LN, Jaradat SA, Su SY, Tay GK, Hulse GK
Pharmacogenomics and Personalized Medicine 2012, 5:99-111
Published Date: 7 September 2012
Role of pharmacogenomics in the treatment of tuberculosis: a review
Ramachandran G, Swaminathan S
Pharmacogenomics and Personalized Medicine 2012, 5:89-98
Published Date: 13 September 2012
Pharmacogenomic considerations in opioid analgesia
Vuilleumier PH, Stamer UM, Landau R
Pharmacogenomics and Personalized Medicine 2012, 5:73-87
Published Date: 23 August 2012
Individualized immunosuppression in transplant patients: potential role of pharmacogenetics
Abboudi H, MacPhee IA
Pharmacogenomics and Personalized Medicine 2012, 5:63-72
Published Date: 18 June 2012
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics
Barratt DT, Coller JK, Hallinan R, Byrne A, White JM, Foster DJR, Somogyi AA
Pharmacogenomics and Personalized Medicine 2012, 5:53-62
Published Date: 18 April 2012
The role of genetics in pre-eclampsia and potential pharmacogenomic interventions
Williams PJ, Morgan L
Pharmacogenomics and Personalized Medicine 2012, 5:37-51
Published Date: 20 January 2012
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
Kenna GA, Roder-Hanna N, Leggio L, Zywiak WH, Clifford J, Edwards S, Kenna JA, Shoaff J, Swift RM
Pharmacogenomics and Personalized Medicine 2012, 5:19-35
Published Date: 13 January 2012
Individualization of antiretroviral therapy
Pavlos R, Phillips EJ
Pharmacogenomics and Personalized Medicine 2012, 5:1-17
Published Date: 29 December 2011